Dose-response effects of orexin-A on food intake and the bahavioural satiety sequence in rats

被引:94
作者
Rodgers, RJ [1 ]
Halford, JCG
de Souza, RLN
de Souza, ALC
Piper, DC
Arch, JRS
Blundell, JE
机构
[1] Univ Leeds, Sch Psychol, Leeds LS2 9JT, W Yorkshire, England
[2] Univ Liverpool, Dept Psychol, Liverpool L69 7NZ, Merseyside, England
[3] SmithKline Beecham Pharmaceut, Harlow CM19 5AD, Essex, England
关键词
o(r)exin-A; food intake; behavioural satiety sequence; microstructural analysis of behaviour; rat;
D O I
10.1016/S0167-0115(00)00203-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although intracerebroventricular (i.c.v.) administration of orexin-A has been reported to stimulate food intake and/or feeding behaviour in rats, mice and goldfish, little attention has thus far been paid to its effects on normal patterns of feeding. In the present study, a continuous monitoring technique was used to characterise the effects of this novel neuropeptide on the microstructure of rat behaviour during a 1-h test with palatable wet mash. Particular attention was devoted to the behavioural satiety sequence, in which feeding is followed by grooming and resting. Although results confirmed the hyperphagic effects of orexin-A (3.33-30.0 mug i.c.v.), gross behavioural analysis failed to reveal any reliable effects of peptide treatment on eating, drinking, sniffing, grooming, resting, locomotion or rearing. However, microstructural analysis revealed behavioural effects of orexin-A that are both dose- and time-dependent. At lower doses (3.33-10.0 mug), orexin-A primarily delayed behavioural satiety, i.e. the normal transition from eating to resting. In contrast, the 30 mug dose initially induced a sedative-like effect, significantly suppressing eating and other active behaviours for the first 15-20 min of the test period. This sedative-like effect resulted in a phase-shifting of the entire behavioural sequence with higher than control levels of eating, grooming, locomotion, rearing and sniffing observed over the second half of the test session. Present findings illustrate the advantages of microstructural behavioural analysis and suggest that the hyperphagic response to low doses of orexin-A results largely from a delay in behavioural satiety while that seen in response to high doses may occur in rebound to initial behavioural suppression. Further studies will be required to confirm the identity of the specific orexin receptors (i.e. OX1 or OX2) involved in mediating the dose-dependent behavioural effects reported. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:71 / 84
页数:14
相关论文
共 52 条
[21]   Behavioral satiety sequence (BSS) for the diagnosis of drug action on food intake [J].
Halford, JCG ;
Wanninayake, SCD ;
Blundell, JE .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1998, 61 (02) :159-168
[22]   Metergoline antagonizes fluoxetine-induced suppression of food intake but not changes in the behavioural satiety sequence [J].
Halford, JCG ;
Blundell, JE .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1996, 54 (04) :745-751
[23]  
HALFORD JCG, 1993, BRIT J PHARMACOL, V110, pP95
[24]   Hypothalamic orexin A-immunoreactive neurons project to the rat dorsal medulla [J].
Harrison, TA ;
Chen, CT ;
Dun, NJ ;
Chang, JK .
NEUROSCIENCE LETTERS, 1999, 273 (01) :17-20
[25]   Effects of single and chronic intracerebroventricular administration of the orexins on feeding in the rat [J].
Haynes, AC ;
Jackson, B ;
Overend, P ;
Buckingham, RE ;
Wilson, S ;
Tadayyon, M ;
Arch, JRS .
PEPTIDES, 1999, 20 (09) :1099-1105
[26]  
HOVARTH TL, 1999, J COMP NEUROL, V415, P145
[27]   Targeted disruption of the melanocortin-4 receptor results in obesity in mice [J].
Huszar, D ;
Lynch, CA ;
FairchildHuntress, V ;
Dunmore, JH ;
Fang, Q ;
Berkemeier, LR ;
Gu, W ;
Kesterson, RA ;
Boston, BA ;
Cone, RD ;
Smith, FJ ;
Campfield, LA ;
Burn, P ;
Lee, F .
CELL, 1997, 88 (01) :131-141
[28]   Effect of lateral cerebroventricular injection of the appetite-stimulating neuropeptide, orexin and neuropeptide Y, on the various behavioral activities of rats [J].
Ida, T ;
Nakahara, K ;
Katayama, T ;
Murakami, N ;
Nakazato, M .
BRAIN RESEARCH, 1999, 821 (02) :526-529
[29]  
IVANOV AY, 1999, SOC NEUR ABSTR, V25
[30]  
JAIN MR, 1998, SOC NEUR ABSTR, V24